The rational design of improved diagnostic tests and effective vaccines against tuberculosis requires an improved understanding of the immune response to infection, particularly during the initial stages, about which little is known. Central to understanding immunity to tuberculosis is the interaction between mycobacteria and the cell ultimately responsible for their destruction, the macrophage. To survive and multiply within the host, Mycobacterium bovis must adapt to the hostile intracellular environment of the macrophage. A feature of mycobacteria is their ability to resist the microbicidal activities of macrophages (27) . Following phagocytosis, virulent mycobacteria reside within phagosomes and are thought to avoid microbicidal activity by limiting lysosomal fusion and subsequent acidification of the phagosomal vacuole (11, 27) . The subsequent intracellular growth and replication of mycobacteria are confined primarily to phagosomes, at least during the initial stages of infection. It is arguably these preliminary stages of intracellular residence that determine mycobacterial survival and whether the bacilli are able to successfully replicate.
In hosts which are susceptible to infection, virulent mycobacteria are able to replicate within macrophages. During the critical initial stages of intracellular survival and growth, it is possible that mycobacteria will generate molecules which can be recognized by the host's immune surveillance (1, 17, 23) . In turn, lymphocyte-mediated responses generated by antigens derived from the early stages of intracellular mycobacterial growth have the potential to contribute to immune protection by the host or, conversely, to mechanisms of pathogenesis. However, the ability of infected macrophages to generate immunoreactive molecules remains uncertain, particularly during the early stages of infection.
While intracellular growth and replication of mycobacteria are confined primarily to phagosomes, at least during the initial stages of infection, there is recent evidence in mice and humans for stimulation of T cells which recognize antigens released into the cytosol (13, 18, 20, 23, 28) . More recently, a subclass of T cells which recognizes mycobacterial lipids presented by the nonclassical major histocompatibility complex (CD1) has been identified (25, 30) . Data from these publications suggest that some mycobacterial products are able to escape the phagosome and enter the cytosol and that nonpeptide mycobacterial antigens are capable of being recognized by T cells.
In the present study, we sought to determine whether M. bovis actively replicating within alveolar macrophages (AMs) in vitro released antigens into the extracellular milieu. For these studies, we used AMs derived from red deer (Cervus elaphus). Red deer are a naturally susceptible host for M. bovis (16, 21) , and large numbers of AMs can be isolated from the lungs of deer for experimental purposes. We demonstrate that AMs infected with M. bovis in vitro generate lipid molecules that can stimulate proliferation of lymphocytes derived from M. bovis-infected deer. These molecules are secreted into the extracellular environment soon after infection and may there-fore be important determinants of immunity against tuberculosis in vivo.
MATERIALS AND METHODS
Bacteria. The two strains of mycobacteria used were M. bovis BCG Pasteur 1173P2 and virulent M. bovis strain 83/6235, which was originally isolated from a tuberculous lesion in a brushtail possum and has been used in previous macrophage infection studies (3, 7) . The strains were grown to mid-log phase in Middlebrook 7H9 broth (Difco Laboratories, Detroit, Mich.) supplemented with Tween 80, 0.006% (vol/vol) alkalinized oleic acid, 0.5% (wt/vol) albumin (fraction V), and 0.25% (wt/vol) glucose. Bacteria were washed twice in phosphatebuffered saline (PBS) and stored in frozen aliquots at Ϫ70°C. Prior to use in infection experiments, both strains were thawed and sonicated for 75 s at 40 W in a sonicating water bath (Branson, Shelton, Conn.).
Animals. Red deer (Cervus elaphus) were treated as follows. A group of five deer were challenged via the intratonsillar route with 100 to 500 CFU of a virulent M. bovis strain (MES/89, isolated from a field case of tuberculosis in deer) (21) . For some experiments, a second group of three deer served as nonsensitized controls. M. bovis-inoculated deer were grazed separately from the control deer at a quarantined deer farm. Blood samples were collected from the jugular vein into heparinized Vacutainer tubes.
Preparation of AMs. Lung-derived macrophages were obtained from freshly excised lungs of healthy deer by methods previously described for preparing bovine AMs (35) . Briefly, 1 to 2 liters of sterile PBS was introduced into the trachea, and the lung lobes were gently massaged for 5 to 10 min. Lavage fluid was collected, and cells were washed twice in warm PBS. Cells were resuspended at 5 ϫ 10 5 /ml in RPMI supplemented with 2% normal deer serum and 50 U of penicillin G per ml (supplemented RPMI). For production of macrophage supernatants (MSs), 50 ml of cell suspension was seeded into 175-cm 2 tissue culture flasks (Falcon). For assessment of intracellular growth, 100 l of AM suspension was added per well of flat-bottomed 96-well tissue culture microtiter plates (Nunclon). Cells were allowed to adhere for 2 h, after which nonadherent cells were removed by gentle washing with warm PBS. Adherent cell populations routinely comprised over 95% macrophages, as determined by microscopic examination following Giemsa and nonspecific esterase staining.
Assessment of mycobacterial growth. Intracellular growth of M. bovis BCG and virulent M. bovis was determined by metabolic labeling with tritiated uracil as described previously (2, 35 After incubation for 4 h at 37°C in a 5% CO 2 -95% air atmosphere, monolayers were washed three times with warm PBS to remove extracellular bacteria. The supernatant from the third wash was centrifuged at 2,000 ϫ g, and the pellet was resuspended and examined microscopically for the presence of acid-fast bacilli. After the final wash, 100 ml of RPMI containing 50 U of penicillin G per ml (a concentration which was previously determined not to inhibit intracellular growth of M. bovis or BCG) was added to the flasks, which were incubated for a further 48 h at 37°C in a 5% CO 2 -95% air atmosphere.
Aliquots of serum-free MS were collected from tissue culture flasks and filtered through 0.20-m-pore-size filters (Acrodisc, Gellman Sciences, Mich.). Filtered supernatants were concentrated 15-fold on an Amicon YM 3 membrane (Amicon, Danvers, Mass.) and further filtered through 0.20-m-pore-size filters to yield a final volume of 50 to 60 ml per liter of supernatant. The protein concentration in the concentrated supernatant fractions was estimated by the Bradford method (Bio-Rad Laboratories, Richmond, Calif.). Supernatant fractions were standardized on the basis of protein estimation, aliquoted, and stored at Ϫ70°C for use in lymphocyte proliferation assays (LPAs). M. bovis culture filtrate (CF) for use in LPAs and Western blotting was prepared from M. bovis grown to mid-log phase in Middlebrook 7H9 broth, filtered through 0.20-mpore-size filters, and concentrated 15-fold on an Amicon YM 3 membrane.
LPA. LPAs were carried out as previously described (9) with antigen-sensitized lymphocytes obtained from M. bovis-infected deer at 5 weeks postinoculation. Briefly, peripheral blood lymphocytes (PBLs) were isolated from heparinized venous blood samples by centrifugation on Ficoll-Conray. Cells were washed and resuspended at a concentration of 2.5 ϫ 10 6 /ml in RPMI 1640 (GIBCO, Grand Island, N.Y.) supplemented with 2 mM glutamine, gentamicin (80 g/ml), and 10% pooled normal deer serum. Aliquots of 100 l were dispensed into 96-well flat-bottom microtiter trays (Nunclon). Fifty microliters of concentrated MS fractions (protein estimation, 20 to 100 g/ml), lipid-extracted MS fractions (100 g/ml), mycolic acid from M. tuberculosis (100 g/ml) (Sigma), lipid-extracted M. bovis CF (100 g/ml), or medium alone was added to wells in triplicate. After incubation for 72 h, (5) . Supernatant (0.2 volume) was mixed with chloroform-methanol (2:1 [vol/vol]) and stirred for 4 h at room temperature. The aqueous phase (containing proteins, salts, and other polar molecules) was separated from the organic phase (mostly lipids), and the organic phase was dried in a rotoevaporator (Buchi, Flawil, Switzerland). Lipid extracts were weighed, resuspended at 100 g/ml in PBS-Tween (PBST) at 40°C, and stored at 4°C for use in thin-layer chromatography (TLC) analysis and LPAs. Lipid fractions of MS were loaded into silica gel TLC plates (Whatman grade 3MM; Sigma). TLC plates were developed twice in chloroform-methanol (2:1 [vol/vol]). Lipid extracts were visualized by staining with iodine crystals (29) , and ninhydrin spray (Sigma) was used to stain lipids with free amino groups (26) . Lipid-extracted MSs were incubated with excess chymotrypsin (10-fold excess by weight; Sigma) or proteinase K (200 g/ml; Boehringer Mannheim) for 1 h at 37°C, followed by addition of Bowman soybean inhibitor (20-fold excess by weight; Sigma) and were further tested for lymphoproliferative responses in M. bovis-infected deer.
SDS-PAGE and Western blotting. M. bovis CF, mycolic acid, concentrated MS from M. bovis-or BCG-infected AMs, and lipid-extracted MS from M. bovis-or BCG-infected AMs were prepared as described above. Bovine purified protein derivative (PPDB; CSL, Melbourne, Australia), M. bovis CF, mycolic acid, and lipid-extracted MS were used at a concentration of 100 g/ml, and concentrated MSs were used at 20 to 100 g/ml.
For silver staining, analytical sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was carried out with 10 to 20% gradient gels (16 by 16 by 0.075 cm) under reducing conditions as described by Laemmli (19) . For calibration, low-molecular-weight standard markers (Bio-Rad) were run in parallel with the samples. The gels were visualized by silver staining.
For Western blotting, antigens were separated electrophoretically by SDS-PAGE (8% polyacrylamide), as described by Laemmli (19) , with a Mini-Protean 3 (Bio-Rad). Antigens were transferred electrophoretically to Trans-Blot transfer medium (pure nitrocellulose; Bio-Rad), with a Mini Trans-Blot transfer cell with buffer (25 mM Tris HCl [pH 8.3], 192 mM glycine, 20% methanol), for 1.5 h at 100 V at 4°C. A rabbit polyclonal antibody against M. bovis sonicate (a gift from J. Pollock, Stormont, Northern Ireland) used at a 1:500 dilution provided the primary antibody. Following incubation with affinity-purified goat anti-rabbit peroxidase-conjugated immunoglobulin G (Gibco, Grand Island, N.Y.) at a dilution of 1:5,000, development was carried out as recommended in the ECL (enhanced chemiluminescence) Western blotting detection system kit (Amersham Pharmacia Biotech, Little Chalfont, United Kingdom). (Fig. 3) . Lymphoproliferative activity in M. bovis-sensitized PBLs was not detected in supernatants derived from noninfected AMs. This suggests that supernatants derived from AMs infected with live bacteria are required for stimulation of lymphoproliferative responses.
RESULTS

Confirmation that
Lymphoproliferative antigens are present in lipid extracts of MS. Supernatants derived from BCG-and M. bovis-infected AMs and M. bovis CF were subjected to chloroform-methanol extraction to determine whether lymphoproliferative antigens could be separated by extraction procedures selective for lipids. Figure 4 shows that lipid-extracted MS derived from AMs infected with live BCG or M. bovis, but not uninoculated control MS, mycolic acid, or lipid-extracted M. bovis CF stimulated lymphoproliferative responses in PBLs from M. bovis-infected deer, but not uninfected controls. The proliferation responses were considerably stronger for lipid extracts from M. bovisinfected compared to BCG-infected AM supernatants. To test whether these extraction procedures were selective for lipids, AM-derived supernatants were run on TLC plates and stained with iodine to identify lipids or with ninhydrin to detect amino acids. Figures 5 and 6 show that lipid-extracted MS stained with iodine, but not ninhydrin, indicating that the lymphoproliferative antigens were nonproteinaceous. Lipid extracts which were incubated with excess chymotrypsin or proteinase K for 1 h at 37°C followed by addition of Bowman soybean inhibitor retained lymphoproliferative activity (data not shown), further These results show that lipid-extracted M. bovis-specific lymphoproliferative antigens were not detected by silver staining, suggesting that lymphoproliferative antigens were not proteins. Based on these results, we decided to test lipid-extracted MS for the presence of M. bovis-specific antigens by Western blotting.
Mycobacterial antigens from BCG or M. bovis MS, but not lipid-extracted supernatants, are detected by Western blotting.
To further demonstrate that lymphoproliferative antigens in MS were derived from mycobacteria, we used a rabbit polyclonal antibody generated against sonicated M. bovis to detect M. bovis-specific antigens by Western blotting. Figure 8 shows that supernatants derived from AMs infected with live M. bovis or BCG (lanes 3 and 4) are detected by the anti-M. bovis antibody. This antibody also recognized M. bovis culture filtrate antigens and PPDB (lanes 1 and 7) , but not mycolic acid (lane 2) or lipid-extracted MS (lanes 5 and 6). This suggests that the rabbit antibody recognizes BCG and M. bovis protein antigens in MS, but not antigens derived from lipid-extracted BCG or M. bovis MS. While these observations support the hypothesis that lymphoproliferative protein antigens in BCGor M. bovis-infected MS are derived from mycobacterial sources and not macrophages, they also show that lymphoproliferative lipid antigens are not recognized by polyclonal antibody against M. bovis sonicate.
Statistical analysis. Analyses of data for [ 3 H]uracil incorporation assays and LPAs were undertaken by analysis of variance of raw data.
DISCUSSION
AMs are generally regarded as efficient defense cells, generating a range of microbicidal responses following phagocytosis, such as reactive oxygen and nitrogen intermediates (12) . Mycobacteria that reside within the intracellular environment must therefore resist such microbicidal mechanisms in order to survive and replicate. It has been previously considered that, at least during the early stages of infection, virulent mycobacteria reside exclusively within intracellular phagosomal vacuoles and therefore have little communication with the cytosol or the extracellular environment (14, 22, 27) . However, recent studies have indicated that CD8 ϩ T cells are active during mycobacterial infection of macrophages in vitro, suggesting that some antigenic material can exit the phagosome and enter the endogenous (cytosolic) antigen-processing mechanism (20, 34) . Previously, investigators have hypothesized that such mycobacterial antigens are leaked or expelled from the host phagosome (24) and that these antigens may be key elements in the sensitization of mycobacterial reactive T cells. More recently, lipid-containing moieties of the mycobacterial cell wall have been shown to actively traffic from the macrophage phagosome for uptake by bystander macrophages (6) . The results of our study have furthered this paradigm, and we have demonstrated here that actively metabolizing intracellular mycobacteria produce antigenic molecules which are subsequently excreted or secreted into the extracellular environment. It is highly likely that these molecules are products of mycobacterial metabolism and/or replication, since no secretory material could be detected in supernatants derived from macrophages exposed to killed mycobacteria in our study. However, it is also possible that recognition of the mycobacterial antigens by lymphocytes is dependent on processing and presentation by macrophages. This result is significant and provides evidence that during the early stages of intracellular mycobacterial replication, molecules are trafficked out of the phagosome and into the extracellular environment, indicating that the mycobacterial phagosome is not a discrete entity.
That the lipid molecules identified in MS were derived from mycobacterial sources was confirmed by immunolabelling with an anti-M. bovis antiserum. While we have no further evidence as to the identity of these molecules, it is most likely that they are derived from the lipid-rich cell wall of M. bovis. A distinguishing characteristic of mycobacteria is the presence of a thick waxy cell wall (8, 10) , and up to 80% of the biomass of mycobacteria may comprise cell wall components. Outer cell wall components, such as mycolic acids and lipoarabinomannan, may be shed as the bacteria divide in macrophages and may be released from phagosomal compartments (10, 27) . Furthermore, lipoarabinomannan has been shown to be transported from the mycobacterial vacuole into lysosomal compartments within viable macrophages (36) . Recent studies have shown that mycobacterial cell wall components may enter the CD1 antigen presentation pathway and be presented to CD1-restricted T cells (24, 33) , or they may be released by exocytosis following cell lysis (25) .
Extracellular production of mycobacterial lipids due to lysis of macrophages is unlikely, since a low MOI was used, and at the time point when supernatants were collected, this MOI has been shown not to affect the integrity of alveolar macrophages (2) . Mycobacterial lipids which were not derived from macrophages, such as mycolic acid and those prepared from M. bovis CF, failed to stimulate proliferative responses. We therefore conclude that mycobacterial lipid antigens, detected in the supernatants of live M. bovis-infected AMs, are most likely to be cell wall derivatives of intracellular bacterial cell replication.
Molecules secreted or excreted by infected host cells have the possibility to stimulate immune recognition in the host. Many of the key mycobacterial antigens recognized by the acquired immune response have been shown to be exported or secreted from living bacteria (4), while recent studies have indicated that mycobacterial lipids in particular can stimulate CD1-restricted responses in immunologically primed lymphocyte populations (31) (32) (33) mononuclear cell populations can be derived from animals sensitized to mycobacteria during natural infection. An intratonsillar infection model has been established for red deer, and the ensuing patterns of pathogenesis and immune reactivity in diseased animals closely mimic the patterns observed in naturally infected farmed deer (9, 16) . In this context, we have demonstrated here that lymphocytes derived from the peripheral blood of deer infected with M. bovis recognize lipid molecules derived from M. bovis-infected AMs. It is known that deer produce strong lymphocyte reactivity against proteinaceous mycobacterial antigens during tuberculosis infection (15) and that these responses are due to interleukin-2-dependent CD4, CD8, and ␥␦ T-cell subsets (9); however, this is the first report of lymphocyte responses being directed against lipid extracts. This novel antigen recognition may provide a valuable diagnostic tool for determining mycobacterial infection in farmed animals and furthermore opens up the possibility that lipid antigen-based immunoassays may be developed as a diagnostic tool for infection in veterinary species and humans.
In summary, this is the first report of the detection of mycobacterial lipid antigens released from host macrophages which are capable of stimulating specific lymphoproliferative responses. Our results suggest that M. bovis growing in macrophages secretes lipids which can escape the phagosome, enter the cytosol, and subsequently be released into the extracellular milieu. Furthermore, these extracellular lipids are capable of stimulating lymphocyte proliferation responses in vitro. Mycobacterial antigens released by AMs in vivo following aerogenic infection of the lungs may be important in controlling the early immune response to tuberculosis. Identification of macrophage-induced mycobacterial antigens will assist in understanding the mechanisms by which virulent mycobacteria cause disease. Immune recognition of lipids produced by M. bovis growing in macrophages suggests that mycobacterial antigens other than proteins are capable of stimulating proliferation of sensitized lymphocytes. We are currently characterizing the lipid antigens and the lymphocyte subsets which recognize them.
